Submission Details
| 510(k) Number | K012978 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | July 06, 2001 |
| Decision Date | September 18, 2001 |
| Days to Decision | 74 days |
| Submission Type | Traditional |
| Review Panel | Toxicology (TX) |
| Summary | Statement |
K012978 is an FDA 510(k) clearance for the RANDOX GENTAMICIN, a Enzyme Immunoassay, Gentamicin (Class II — Special Controls, product code LCD), submitted by Randox Laboratories, Ltd. (Crumlin, IE). The FDA issued a Cleared decision on September 18, 2001, 74 days after receiving the submission on July 6, 2001. This device falls under the Toxicology review panel. Regulated under 21 CFR 862.3450.
| 510(k) Number | K012978 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | July 06, 2001 |
| Decision Date | September 18, 2001 |
| Days to Decision | 74 days |
| Submission Type | Traditional |
| Review Panel | Toxicology (TX) |
| Summary | Statement |
| Product Code | LCD — Enzyme Immunoassay, Gentamicin |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 862.3450 |